InGeneron is a clinical-stage biotechnology company based in Houston, TX, specializing in developing cell-based therapies to revolutionize orthopedic care. With over 16 years of research and numerous peer-reviewed publications, the company is dedicated to providing patients with innovative regenerative cell therapies as an alternative to traditional treatments like surgery and corticosteroid injections.
Utilizing their proprietary Transpose RT process, InGeneron harvests regenerative cells from adipose tissue to create personalized therapies for orthopedic conditions such as rotator cuff tendinopathy, shoulder facet joint syndrome, spine issues, and wrist osteoarthritis. By focusing on evidence-based treatments approved by the FDA, InGeneron is at the forefront of advancing regenerative medicine and improving the quality of life for individuals suffering from chronic joint pain.
Generated from the website